Ola Rönn
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Pharmacology and Obesity Treatment
- Drug-Induced Hepatotoxicity and Protection
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Analytical Methods in Pharmaceuticals 7
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Per LundborgC G RegårdhG. JohnssonBoo EdgarL. JordöB. EdgarChristina GraffnerP O Lagerström
In The Last Decade
Ola Rönn
25 papers receiving 491 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 142
- Analytical Chemistry 83
- Cardiology and Cardiovascular Medicine 172
- Pharmacology 119
- Pharmaceutical Science 30
Countries citing papers authored by Ola Rönn
This map shows the geographic impact of Ola Rönn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Rönn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Rönn more than expected).
Fields of papers citing papers by Ola Rönn
This network shows the impact of papers produced by Ola Rönn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Rönn. The network helps show where Ola Rönn may publish in the future.
Co-authors
The 25 scholars most cited alongside Ola Rönn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 15 | |
| 2 | 2015 | 6 | |
| 3 | 1998 | 4 | |
| 4 | 1995 | 5 | |
| 5 | 1995 | 4 | |
| 6 | Characterization of responders and nonresponders to tiaprofenic acid and naproxen in the treatment of patients with osteoarthritis. | 1993 | 10 |
| 7 | 1990 | 12 | |
| 8 | 1988 | 16 | |
| 9 | 1987 | 1 | |
| 10 | 1985 | 19 | |
| 11 | 1985 | 42 | |
| 12 | 1985 | 98 | |
| 13 | 1982 | 2 | |
| 14 | Human pharmacological studies on prenalterol - a selective beta-1-adrenoceptor agonist | 1981 | 2 |
| 15 | 1981 | 7 | |
| 16 | 1980 | 27 | |
| 17 | Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers. | 1980 | 25 |
| 18 | 1979 | 69 | |
| 19 | 1979 | 7 | |
| 20 | 1979 | 20 |
About Ola Rönn
Ola Rönn is a scholar working on Analytical Chemistry, Pharmacology, Animal Science and Zoology, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 25 papers that have together received 545 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (7 papers), Cardiac electrophysiology and arrhythmias (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Blood Pressure and Hypertension Studies (4 papers), Pharmacological Effects and Assays (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Receptor Mechanisms and Signaling (3 papers) and Heart Rate Variability and Autonomic Control (3 papers). The work is most often cited by research in Pharmacology (142 citations), Analytical Chemistry (83 citations), Cardiology and Cardiovascular Medicine (172 citations), Pharmacology (119 citations) and Pharmaceutical Science (30 citations). Ola Rönn has collaborated with scholars based in Sweden, Spain and Norway. Frequent co-authors include Per Lundborg, C G Regårdh, G. Johnsson, Boo Edgar, L. Jordö, B. Edgar, Christina Graffner, P O Lagerström, L. E. B. Johansson and Bengt Bengtsson. Their work appears in journals such as Drugs, Journal of Cardiovascular Pharmacology, Analytical Biochemistry, British Journal of Clinical Pharmacology and Biopharmaceutics & Drug Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.